ID

25854

Description

Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Montral Cognitive Assessment (MoCA)

Keywords

Versions (1)
  1. 9/21/17 9/21/17 -
Copyright Holder

GlaxoSmithKline

Uploaded on

September 21, 2017

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

MoCA GSK study Chronic Coronary Heart Disease NCT00799903

English

MoCA GSK study Chronic Coronary Heart Disease NCT00799903

1 forms  
MoCA General information
Description

MoCA General information

1. Date of visit/assessment
Description

Date of visit/assessment

Data type

date

Informed consent
Description

Informed consent

Data type

text

MoCA Eligibility Question
Description

MoCA Eligibility Question

1. Did subject meet all MoCA eligibility criteria?
Description

MoCA eligibility criteria met

Data type

text

[I51] 1. Availability of an approved translation
Description

Inclusion criterion

Data type

boolean

[I52] 2. Signed written informed consent prior to assessing the MoCA. Note: Consent to participate in the MoCA assessment is seperate from consent to participate in the parent study.
Description

Inclusion criterion

Data type

boolean

[E51] 1. Inability to complete all items on the MoCA due to physical limitation(s)
Description

Exclusion criterion

Data type

boolean

Montreal Cognitive Assessment
Description

Montreal Cognitive Assessment

MoCA Status
Description

MoCA Status

Data type

text

Montreal Cognitive Assessment (MoCA)
Description

Montreal Cognitive Assessment (MoCA)

Data type

text

Back to the top of the page

Similar models

MoCA GSK study Chronic Coronary Heart Disease NCT00799903

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
MoCA General information
Date of visit/assessment
Item
1. Date of visit/assessment
date
Informed consent
Item
Informed consent
text
Item Group
MoCA Eligibility Question
Item
1. Did subject meet all MoCA eligibility criteria?
text
MoCA eligibility criteria met
Code List
1. Did subject meet all MoCA eligibility criteria?
CL Item
Yes (Y)
CL Item
No, please select all boxes corresponding to the criteria that were not met (N)
Availability of an approved translation
Item
[I51] 1. Availability of an approved translation
boolean
informed consent
Item
[I52] 2. Signed written informed consent prior to assessing the MoCA. Note: Consent to participate in the MoCA assessment is seperate from consent to participate in the parent study.
boolean
physical limitation
Item
[E51] 1. Inability to complete all items on the MoCA due to physical limitation(s)
boolean
Item Group
Montreal Cognitive Assessment
MoCA Status
Item
MoCA Status
text
Montreal Cognitive Assessment (MoCA)
Item
Montreal Cognitive Assessment (MoCA)
text
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial